What is female Viagra (Sildenafil)?

In today’s world, where men’s sexual health is openly discussed, women’s sexuality often remains in the shadows. However, sexual well-being is an integral part of every woman’s overall health and quality of life. That is why there is a growing interest in drugs that can help women achieve sexual harmony. One such drug that is causing considerable interest and discussion is the so-called “female Viagra”.

For years, the term “Viagra” has been closely associated with male sexual health, including the treatment of erectile dysfunction. However, the concept of “female Viagra” is more complex and multifaceted than it might seem at first glance. It is not simply an analogue of male Viagra for women, but a separate category of drugs designed to solve specific sexual health problems that women face.

In this comprehensive guide, we delve into the world of “female Viagra,” revealing its true nature, mechanisms of action, indications for use, potential benefits, and risks. We’ll look at the different types of drugs that fall into this category, as well as discuss alternative approaches to improving women’s sexual health. Our goal is to provide you with complete and objective information so you can make informed choices about your sexual well-being.

Understanding Female Sexual Dysfunction (FSD)

Before delving into the specifics of “female Viagra,” it’s important to understand the problem it’s designed to solve: female sexual dysfunction (FSD). FSD is a general term that covers a variety of problems that women can experience at any stage of sexual response. These problems can include:

• Sexual desire disorders: Persistent or recurring absence or decrease in sexual desire, sexual fantasies, and interest in sexual activity.
• Arousal disorders: Difficulty achieving or maintaining sufficient arousal during sexual activity. This may manifest as inadequate vaginal lubrication, decreased genital sensation, or problems with physical arousal.
• Orgasmic disorders: Delayed, infrequent orgasms, or complete absence of orgasm (anorgasmia) during sexual activity despite sufficient stimulation and arousal.
• Pain disorders: pain during sexual intercourse (dyspareunia) or vaginal spasms when attempting penetration (vaginismus).

FSD is a common condition that can affect women of all ages, regardless of sexual orientation or marital status. Estimates vary between 30% and 50% of women worldwide experience some form of sexual dysfunction. The causes of FSD can be varied and often a combination of physical, psychological and social factors.

Factors contributing to the development of FSD

• Physical factors:

  • Hormonal changes: Decreased estrogen levels during menopause, postpartum, breastfeeding, or certain medical conditions can affect sexual desire and arousal.
  • Chronic Diseases Diabetes, cardiovascular disease, multiple sclerosis, arthritis and other chronic diseases can affect the nervous system, circulation and hormonal balance, which can lead to FSD.
  • Taking medications Some medications, such as antidepressants, antihypertensive drugs, birth control pills, and antihistamines, can have side effects that affect sexual function.
  • Surgery: Pelvic surgeries such as hysterectomy or mastectomy can affect nerves, blood supply, and body image, which may contribute to the development of FSD.

• Psychological factors:

  • Stress and anxiety: Chronic stress, work or financial problems, family conflicts can significantly reduce sexual desire and arousal.
  • Depression and other mental disorders: Depression, anxiety disorders, post-traumatic stress disorder and other mental disorders are often accompanied by sexual dysfunction.
  • Relationship problems: conflicts, lack of emotional intimacy, problems communicating with your partner can negatively affect sexual desire and satisfaction.
  • Negative perception of one’s own body and lack of confidence in one’s attractiveness can reduce sexual desire and arousal.
  • Previous traumatic experiences: Childhood sexual abuse and abuse can have long-term consequences for sexual health.

• Social factors:

  • Cultural and religious beliefs: Strict cultural or religious norms about sexuality can suppress sexual desire and lead to feelings of guilt or shame associated with sexuality.
  • Lack of Sexuality Education: Insufficient or distorted information about sexuality can lead to misunderstandings, anxieties, and sexual problems.
  • Social isolation: Lack of social support and feelings of loneliness can negatively impact emotional well-being and sexual desire.

It is important to remember that FSD is not normal and women who experience these issues should not suffer in silence. There are many effective treatments and support options that can help women regain the joy and pleasure of their sex lives. “Female Viagra” is just one option that may be considered in certain cases.

“Female Viagra”: myth or reality?

The term “female Viagra” is often used in the media and in common parlance to refer to drugs designed to improve sexual function in women. However, it is important to understand that unlike male Viagra (sildenafil), which acts primarily on the physical level by improving blood flow to the penis, “female Viagra” has a more complex mechanism of action and affects primarily the brain.

In fact, there are currently two drugs approved by the U.S. Food and Drug Administration (FDA) to treat certain types of female sexual dysfunction:

• Flibanserin (Addyi): Often referred to as the “female Viagra” in the media, Flibanserin acts on neurotransmitters in the brain, specifically serotonin and dopamine, to restore balance that may be out of balance in women with hypoactive sexual desire disorder (HSDD). HSDD is characterized by a persistent or intermittent lack or decrease in sexual desire that causes significant distress or interpersonal difficulties.
• Bremelanotide (Vyleesi): This drug is also FDA-approved for the treatment of HSDD in premenopausal women. Bremelanotide is a synthetic peptide that acts as an agonist of melanocortin receptors, which play a role in sexual arousal and desire. Bremelanotide is given as an as-needed subcutaneous injection about 45 minutes before planned sexual activity.

It is important to note that neither flibanserin nor bremelanotide are analogs of male Viagra. They do not affect the blood supply to the genitals and are not intended to treat problems with physical arousal. These drugs are aimed at improving sexual desire and reducing the distress associated with low libido. Therefore, calling them “female Viagra” is not entirely accurate, although this term has firmly established itself in the public consciousness.

Flibanserin (Addyi): A Detailed Review

Flibanserin (brand name Addyi) was approved by the FDA in 2015 to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It is a pill taken orally once a day, preferably at bedtime.

Mechanism of action of flibanserin

Flibanserin acts as a multireceptor agonist and antagonist in the central nervous system. It affects the balance of neurotransmitters such as serotonin, dopamine and norepinephrine, which play an important role in regulating mood, emotions and sexual desire.

In particular, flibanserin acts as:

• 5-HT1A Receptor Agonist: Activation of these receptors is associated with reduced anxiety, improved mood, and potential increased sexual desire.
• 5-HT2A receptor antagonist: Blocking these receptors may reduce the inhibitory effects of serotonin on sexual desire.

Flibanserin is thought to help restore the balance of these neurotransmitters in the brains of women with HSDD, which may lead to increased sexual desire and decreased distress associated with low libido.

Efficacy of flibanserin

Clinical studies have shown that flibanserin may be effective for some women with HSDD, but its effectiveness is modest and individualized. On average, women taking flibanserin reported a small increase in the number of satisfying sexual events per month and a small decrease in distress related to low sexual desire compared with placebo.

It is important to understand that flibanserin is not a “miracle pill” that will instantly restore sexual desire. It is a drug that takes time to take effect, and its effectiveness may vary from woman to woman. Flibanserin is not intended for women who have low sexual desire due to relationship problems, medical conditions, or other factors unrelated to neurotransmitter imbalances.

Risks and Side Effects of Flibanserin

Flibanserin has potential side effects, some of which can be serious. The most common side effects include:

• Drowsiness and fatigue: Flibanserin may cause drowsiness, especially at the beginning of treatment. It is recommended to take the drug at bedtime to minimize this effect.
• Dizziness: Flibanserin may cause dizziness, especially with sudden changes in body position.
• Nausea: Some women experience nausea while taking flibanserin.
• Dry mouth: Flibanserin may cause dry mouth.
• Insomnia: Paradoxically, flibanserin may cause insomnia in some women.

More serious, although rarer, side effects include:

• Unconsciousness: Flibanserin may cause loss of consciousness, especially when taken with alcohol or with certain other medications. Do not drink alcohol while taking flibanserin.
• Severe decrease in blood pressure: Flibanserin can cause a significant decrease in blood pressure, especially when combined with alcohol or certain medications.

Because of the risk of serious side effects, flibanserin is available only by prescription and has a special REMS (Risk Evaluation and Mitigation Strategy) program to ensure safe use. Women considering taking flibanserin should be informed of the potential risks and side effects and be prepared to adhere to alcohol restrictions.

Bremelanotide (Vyleesi): An Alternative Approach

Bremelanotide (brand name Vyleesi) is another drug approved by the FDA to treat HSDD in premenopausal women. Unlike flibanserin, bremelanotide is given as an on-demand injection under the skin about 45 minutes before planned sexual activity.

Mechanism of action of bremelanotide

Bremelanotide is a synthetic peptide that acts as an agonist of melanocortin receptors, specifically melanocortin receptor 4 (MC4R). Melanocortin receptors play a role in a variety of physiological processes, including sexual arousal, inflammation, and regulation of energy balance.

Bremelanotide is thought to activate MC4R receptors in the brain, which may lead to increased sexual desire and arousal. The exact mechanism by which bremelanotide works to improve sexual function in women is not fully understood, but research suggests that it may affect neural pathways involved in sexual arousal and motivation.

Efficacy of bremelanotide

Clinical studies have shown that bremelanotide may be effective for some women with HSDD in improving sexual desire and reducing distress associated with low libido. On average, women using bremelanotide reported a small increase in the number of satisfying sexual events per month and a small decrease in distress compared with placebo.

Like flibanserin, bremelanotide’s effectiveness is moderate and individualized. Bremelanotide is not a daily medication and is intended for use “as needed” before sexual activity. This may be more convenient for some women who do not want to take medication every day.

Risks and side effects of bremelanotide

The most common side effects of bremelanotide include:

• Nausea: Nausea is a fairly common side effect of bremelanotide, especially after the first injection. Nausea usually decreases over time.
• Facial flushing Bremelanotide may cause facial flushing.
• Headache Some women experience headache after bremelanotide injection.
• Injection site reactions: Bremelanotide injections may cause redness, pain, or itching at the injection site.
• Temporary darkening of the skin and gums: Bremelanotide may cause temporary darkening of the skin and gums, which usually disappears after treatment is stopped.

Serious side effects of bremelanotide are rare. However, bremelanotide is not recommended for women with uncontrolled high blood pressure or cardiovascular disease. It is important to discuss your medical conditions and medications with your doctor before starting treatment with bremelanotide.

“Female Viagra” vs. Male Viagra: Key Differences

It is important to emphasize that “female Viagra” (flibanserin and bremelanotide) is fundamentally different from male Viagra (sildenafil) in its mechanism of action, indications and method of administration.

As you can see from the table, male Viagra acts primarily physically, helping men achieve and maintain an erection. “Female Viagra,” on the other hand, affects the brain to improve sexual desire and reduce the psychological discomfort associated with low libido. These are fundamentally different drugs, designed to solve different sexual health problems.

Who can benefit from “female Viagra”?

“Female Viagra” (flibanserin and bremelanotide) is not a one-size-fits-all solution for all women with sexual problems. These drugs are FDA-approved only for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. They may be helpful for women who:

• Have persistent or intermittent low sexual desire that is not related to other medical or mental health conditions, relationship problems, or medication.
• Experiencing significant distress or interpersonal difficulties due to low sexual desire.
• Are in premenopause.
• There are no contraindications to taking flibanserin or bremelanotide.

“Female Viagra” is not intended for women who:

• Have low sexual desire due to relationship problems, stress, depression or other psychological factors. In such cases, the primary focus is on addressing the underlying cause rather than medication.
• Have sexual dysfunctions not related to low desire, such as arousal disorders, orgasmic disorders or pain disorders. “Female Viagra” is not effective in treating these problems.
• Are postmenopausal. The efficacy and safety of flibanserin and bremelanotide in postmenopausal women has not been established.
• Pregnant or breastfeeding women. The safety of “female Viagra” during pregnancy and breastfeeding has not been established.
• Have certain medical conditions or take certain medications that may interact with flibanserin or bremelanotide.

Before considering taking “female Viagra,” it is important to consult with your doctor to determine the cause of your sexual dysfunction and determine the most appropriate treatment plan. In some cases, psychotherapy, lifestyle changes, or treatment of an underlying medical condition may be more effective and safer options than medication.

Alternatives to ‘Female Viagra’ to Improve Women’s Sexual Health

It is important to remember that “female Viagra” is not the only way to improve women’s sexual health. There are many other effective approaches that can be considered on their own or in combination with medication. These alternatives include:

• Psychotherapy: Sex therapy, cognitive behavioral therapy, and other types of psychotherapy can help women address psychological factors that contribute to sexual dysfunction, such as stress, anxiety, depression, relationship problems, and negative body image.
• Lifestyle changes:
  • Regular exercise: Physical activity improves circulation, mood, and overall well-being, which can impact sexual desire and arousal.
  • A balanced diet rich in fruits, vegetables, whole grains and lean proteins promotes hormonal balance and overall health .
  • Get Enough Sleep: Not getting enough sleep can negatively impact your hormonal balance, mood, and sexual desire.
  • Stress reduction: Relaxation techniques such as yoga, meditation, deep breathing, and walking in nature can help reduce stress levels and improve sexual health.
  • Stop smoking and limit alcohol consumption: Smoking and excessive alcohol consumption can negatively affect circulation, hormonal balance and sexual function.
• Vaginal moisturizers and lubricants: For women who experience vaginal dryness, vaginal moisturizers and lubricants can help ease discomfort during intercourse and improve sexual pleasure.
• Hormone therapy: For menopausal women, hormone therapy with estrogen may help relieve vaginal dryness and improve sexual desire in some cases. However, hormone therapy has potential risks and should be prescribed by a doctor after carefully weighing the benefits and risks.
• Other treatments: Some women may benefit from other treatments, such as pelvic floor physical therapy (to treat painful disorders) or vacuum therapy devices (to improve arousal).

Choosing the best approach to improving sexual health is individual and should take into account each woman’s specific needs, preferences, and medical history. It is important to discuss your sexual concerns openly with your doctor to develop a personalized treatment plan, which may include a combination of different approaches.

Female Viagra in the Context of Women’s Sexual Health

“Female Viagra” is a term often used to refer to drugs such as flibanserin and bremelanotide, which are approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. It is important to understand that these drugs are not analogous to male Viagra and act on the brain rather than the blood supply to the genitals.

Female Viagra may be effective for some women with GERD, helping them increase sexual desire and reduce the distress associated with low libido. However, the effectiveness of these drugs is moderate and individual, and they have potential risks and side effects.

Before considering taking “female Viagra,” it is important to consult with your doctor to determine the cause of your sexual dysfunction and determine the most appropriate treatment plan. In many cases, psychotherapy, lifestyle changes, and other alternative approaches can be effective and safe options for improving women’s sexual health.

Sexual health is an important part of women’s overall well-being. Openly discussing sexual issues with a doctor and seeking effective treatment and support can help women achieve sexual harmony and improve their quality of life.